Peregrine Ventures
Status
ACTIVE
Global HQ
Or Yehuda, Israel
Countries of investment
- Israel
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
- Series C
Industries
- Fintech
- AI
- Blockchain
- Web3
- IoT
About
Peregrine Ventures is Israel's premier venture capital fund dedicated to early-stage investments within the dynamic healthcare sector. Renowned for its commitment to fostering medical innovation, Peregrine leverages the expertise of its seasoned investment professionals to identify and nurture groundbreaking technologies and solutions. The firm not only provides capital but also strategic guidance and mentorship to its portfolio companies, ensuring they are well-positioned for long-term success in a rapidly evolving market. Through its deep understanding of the healthcare landscape, Peregrine Ventures is committed to making a meaningful impact on patient care and advancing the future of medicine.
Peregrine Ventures is Israel's premier venture capital fund dedicated to early-stage investments within the dynamic healthcare sector. Renowned for its commitment to fostering medical innovation, Peregrine leverages the expertise of its seasoned investment professionals to identify and nurture groundbreaking technologies and solutions. The firm not only provides capital but also strategic guidance and mentorship to its portfolio companies, ensuring they are well-positioned for long-term success in a rapidly evolving market. Through its deep understanding of the healthcare landscape, Peregrine Ventures is committed to making a meaningful impact on patient care and advancing the future of medicine.
Investment Thesis
Peregrine Ventures is dedicated to improving patients’ quality of life by investing in and supporting lifechanging healthcare opportunities.
Manager's Experience
Bringing extensive experience in venture capital, the fund manager has strategically focused on sectors such as technology, healthcare, and consumer goods. With a strong presence in North America and Europe, they have successfully executed over 40 deals, showcasing a data-driven investment style that emphasizes long-term growth. Notable exits include several high-profile IPOs and acquisitions, reflecting their expertise in nurturing companies from early-stage to maturity. Their operator-first approach ensures a hands-on partnership with portfolio companies, driving value creation throughout the investment lifecycle.
Team
Eyal Lifschitz
Ronit Hazan
Lior
Gyora Reppen
Dudi Eldar
Boaz Lifschitz
Portfolio
Aleph Farms
Althea Medical
AnserBio
ArTack Medical
ArtFix
B-Balloon
Bio Protect
Bio Refine
Bluewhite
BrainQ
Cardio Gard
Cardiovalve
CartiHeal
ClearMargin
ConAir Medical
Cordio
Curesign
DairyX
Digma
Eledon
Endomatic
Endostream
EviCure
Eximo
Focal Medical Technology
Hairstetics
HeraCure
Insightec
IonaraBio
Kahr
Kanso Diagnostics
Levation Pharma
Life Therapeutics
Lutris Pharma
Magneto
Magnisity
Momentis Surgical
mPharma
Neovasc
NectinTx
NextVivo
NitiNotes
NLT
OncoRedox
Outsense
Raziel
Restore Medical
Ribon Therapeutics
SinuSafe
Snipe Medical
SuperSpectra
Terrapeutics
Trojan Bio
Validify
Valtech
Variantyx
Visionsense
W Endoluminal Robotics
Wanda Fish
Xerient